María
Reviejo Díaz
Personal Docente, Investigador o Técnico
Publications (8) María Reviejo Díaz publications
filter_list
2025
-
Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance
Biomedicine and Pharmacotherapy, Vol. 187
2024
-
Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events
Journal of Hepatology
-
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345
2022
-
Impact of alternative splicing variants on liver cancer biology
Cancers, Vol. 14, Núm. 1
2021
-
Impact of alternative splicing on mechanisms of resistance to anticancer drugs
Biochemical Pharmacology, Vol. 193
2020
-
Molecular bases of drug resistance in hepatocellular carcinoma
Cancers, Vol. 12, Núm. 6, pp. 1-26
-
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5
2019
-
What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs
Expert Opinion on Drug Metabolism and Toxicology, Vol. 15, Núm. 7, pp. 577-593